<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03925025</url>
  </required_header>
  <id_info>
    <org_study_id>AC19003</org_study_id>
    <nct_id>NCT03925025</nct_id>
  </id_info>
  <brief_title>Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning</brief_title>
  <acronym>CCBOC</acronym>
  <official_title>Effectiveness of Calcium Channel Blockade for Organophosphorus and Carbamate Pesticide Poisoning - an Open, Pragmatic, 3-arm RCT Repurposing Two Widely Available Licensed Medicines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Toxicology Society of Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether the addition of intravenous magnesium sulphate or nimodipine to&#xD;
      standard therapy (supportive care plus for all patients atropine and, for OP insecticide&#xD;
      poisoned patients, pralidoxime) benefits patients after acute anticholinesterase&#xD;
      self-poisoning with OP or carbamate insecticides.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 11, 2020</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>through to hospital discharge, median 1 week</time_frame>
    <description>Whether dead or alive at hospital discharge</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">3243</enrollment>
  <condition>Anticholinesterase Insecticide Poisoning</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy plus magnesium sulfate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nimodipine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy plus nimodipine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Treatment in addition to standard therapy</description>
    <arm_group_label>Magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nimodipine</intervention_name>
    <description>Treatment in addition to standard therapy</description>
    <arm_group_label>Nimodipine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 16 years or older with suspected OP or carbamate insecticide&#xD;
             self-poisoning admitted to medical wards with the cholinergic toxidrome requiring&#xD;
             atropine.&#xD;
&#xD;
          -  Diagnosis will be made on the basis of the cholinergic toxidrome clinical features&#xD;
             (eg. small/pinpoint pupils, bronchorrhoea, sweating) or on the history of atropine&#xD;
             administration with beneficial effect. The insecticide involved will be identified&#xD;
             where possible from the history, the bottle brought in by the patient or relative, the&#xD;
             patient/relative identifying the pesticide on a chart showing all locally available&#xD;
             pesticides, and/or relatives sending a photo of the bottle by eg. WhatsApp.&#xD;
&#xD;
          -  Patients who ingest combination products containing OP or carbamate insecticides will&#xD;
             also be included.&#xD;
&#xD;
          -  Inhibited blood cholinesterase activity as shown by routine clinical bedside test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children aged &lt;16 years.&#xD;
&#xD;
          -  Patients who do not require atropine and have not had it prior to presentation during&#xD;
             this episode.&#xD;
&#xD;
          -  Normal blood cholinesterase activity&#xD;
&#xD;
          -  Self-reported known pregnancy (as per South Asian practice, no attempt will be made to&#xD;
             formally test for pregnancy in the patients due to the issue of confidentiality in the&#xD;
             acute care situation in these hospitals and the social consequences of an unexpected&#xD;
             positive response)&#xD;
&#xD;
          -  Known occupational and homicidal poisoning&#xD;
&#xD;
          -  Past medical history of severely impaired renal function&#xD;
&#xD;
          -  Hypersensitivity to magnesium and its salts&#xD;
&#xD;
          -  Patients who have had a myocardial infarction or unstable angina in the last month&#xD;
&#xD;
          -  Patients with traumatic subarachnoid haemorrhage&#xD;
&#xD;
          -  Lack of informed consent (unaccompanied unconscious patients and others)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Eddleston, ScD</last_name>
    <phone>01312426776</phone>
    <email>m.eddleston@ed.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rabbi Chowdhury, MD</last_name>
    <email>mastershakil@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chittagong Medical College</name>
      <address>
        <city>Chittagong</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aniruddha Ghose, MD</last_name>
      <phone>+8801711068841</phone>
      <email>anrdghs@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <reference>
    <citation>Brvar M, Chan MY, Dawson AH, Ribchester RR, Eddleston M. Magnesium sulfate and calcium channel blocking drugs as antidotes for acute organophosphorus insecticide poisoning - a systematic review and meta-analysis. Clin Toxicol (Phila). 2018 Aug;56(8):725-736. doi: 10.1080/15563650.2018.1446532. Epub 2018 Mar 20.</citation>
    <PMID>29557685</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Nimodipine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Six months after primary data analysis is published</ipd_time_frame>
    <ipd_access_criteria>From academic group with clear analysis plan</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

